M
Michael Cecka
Researcher at University of California, Los Angeles
Publications - 25
Citations - 1564
Michael Cecka is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Antigen. The author has an hindex of 11, co-authored 25 publications receiving 1474 citations.
Papers
More filters
Journal ArticleDOI
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
Lorraine C. Racusen,Robert B. Colvin,Kim Solez,Michael J. Mihatsch,Philip F. Halloran,Patricia Campbell,Michael Cecka,Jean Pierre Cosyns,Anthony J. Demetris,Michael C. Fishbein,Agnes B. Fogo,Peter N. Furness,Ian W. Gibson,Denis Glotz,Pekka Häyry,Lawrence Hunsickern,Michael Kashgarian,Ronald H. Kerman,Alex J. Magil,Robert A. Montgomery,Kunio Morozumi,Volker Nickeleit,Parmjeet Randhawa,Heinz Regele,Daniel Serón,Surya V. Seshan,Stale Sund,Kiril Trpkov +27 more
TL;DR: This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001, to be revisited as additional data accumulate in this important area of renal transplantation.
Journal ArticleDOI
Outcomes of kidney transplantation from older living donors to older recipients.
Jagbir Gill,Jagbir Gill,Suphamai Bunnapradist,Gabriel M. Danovitch,David W. Gjertson,John S. Gill,Michael Cecka +6 more
TL;DR: With superior graft and patient survival in recipients of transplants from OLDs compared with SCDs and ECDs, OLD's may be an important option for elderly transplantation candidates and should be considered for older patients with a willing and suitable older donor.
Journal ArticleDOI
CLINICAL OUTCOME OF RENAL TRANSPLANTATION Factors Influencing Patient and Graft Survival
TL;DR: Some of the factors that affect long-term graft and patient survival rates are described.
Journal ArticleDOI
Center‐Defined Unacceptable HLA Antigens Facilitate Transplants for Sensitized Patients in a Multi‐Center Kidney Exchange Program
TL;DR: When transplant centers have flexibility to define crossmatch criteria, it is currently feasible to use virtual crossmatching for highly sensitized patients to reliably predict acceptable cell‐based crossmatches.
Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival.
TL;DR: The success due to HLA matching has improved ever since the introduction of cyclosporine because of the concurrent improvements in tissue typing for Class I and Class II specificities.